300 results on '"Lombardi, Rosa"'
Search Results
2. Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies
3. The 1908 earthquake of Messina: An accounting perspective on the city's reconstruction between faith and Fascism
4. Non-Financial Reporting in the European Union: Current Issues and Prospects
5. Gender Contribution to the Agenda 2030
6. Portal hypertension-like pattern in coronavirus disease 2019 acute respiratory distress syndrome
7. Reflecting on intellectual capital measurement and management in European universities
8. The impact of gender diversity on corporate social responsibility knowledge: empirical analysis in European context
9. Evolution of liver fibrosis in diabetic patients with NAFLD in a follow-up study: Hepatoprotective effects of sodium-glucose co-transporter-2 inhibitors
10. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy
11. Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients
12. Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades
13. Remdesivir-induced bradycardia in patients hospitalized with SARS-CoV2 infection: a possible vagally-mediated mechanism
14. The impact of the EU Directive on non-financial information: Novel features of the Italian case
15. The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic
16. Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study
17. Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity
18. Subclinical and clinical atherosclerosis in non-alcoholic fatty liver disease is associated with the presence of hypertension
19. The disruption of blockchain in auditing – a systematic literature review and an agenda for future research
20. Sustainability performance and social media: an explorative analysis
21. The climate-related information in the changing EU directive on non-financial reporting and disclosure: first evidence by Italian large companies
22. FRI-294 Identification of key predictors of significant weight loss in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: a multicentre study
23. FRI-215-YI MASL-B registry: results from a european cohort of patients with chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease
24. FRI-290 Evaluation of ChatGPT as a counselling tool for Italian-speaking MASLD patients: assessment of accuracy, completeness and comprehensiveness
25. FRI-248-YI The impact of baseline sarcopenia, over time, on liver and cardiovascular damage in patients with metabolic-dysfunction associated steatotic liver disease (MASLD): a prospective study
26. FRI-207-YI Sarcopenia in metabolic-dysfunction associated steatotic liver disease (MASLD): unraveling its role in cardiovascular damage
27. FRI-226 The impact of light to moderate alcohol consumption on liver and cardiovascular damage in metabolic-dysfunction associated steatotic liver disease
28. Role of artificial intelligence in staging and assessing of treatment response in MASH patients.
29. Prevalence of steatosis and cardio-metabolic complications in a cohort of adult patients with growth hormone deficiency: a cross-sectional study
30. Hepatic and adipose tissue transcriptome analysis highlights a commonly deregulated autophagic pathway in severe MASLD
31. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy
32. Role of artificial intelligence in staging and assessing of treatment response in MASH patients
33. Evaluation of ChatGPT as a Counselling Tool for Italian-Speaking MASLD Patients: Assessment of Accuracy, Completeness and Comprehensibility
34. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy
35. Correction to: Usefulness of Fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity
36. Reply: AGILE 3+ score, enhancing the diagnostic accuracy of advanced fibrosis in patients with non alcoholic fatty liver disease
37. What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological Perspectives.
38. The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes.
39. Reply: Diagnostic accuracy of AGILE3+ score for advanced fibrosis in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
40. Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies
41. Author's Reply: “Bacterial infections predispose to the development of portal vein thrombosis in patients with decompensated cirrhosis”
42. Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis
43. Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population
44. Evolution of liver fibrosis in diabetic patients with NAFLD in a follow-up study: Hepatoprotective effects of sodium-glucose co-transporter-2 inhibitors
45. Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients
46. Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis.
47. Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades
48. Metabolic associated fatty liver disease: different impact of the three defining criteria on the hepatic and cardiovascular complications
49. Combined hepatic and adipose tissue transcriptomics highlights circulating NASH biomarkers
50. Hepatic steatosis in people with HIV is associated with lower BMI and more liver fibrosis compared to metabolic dysfunction-associated fatty liver disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.